A mediator reported on Tuesday that members of the Sackler family that own Purdue Pharma and U.S. states opposed to the OxyContin-maker’s bankruptcy exit plan are “even closer” to a settlement over claims that the company fueled a U.S. opioid epidemic. The mediator asked a bankruptcy judge to extend the deadline for negotiations to Feb. 16 from Feb. 7, saying that the two sides need more time to finalize a deal that would involve “substantial” additional money from the Sacklers, according to court documents filed on Tuesday. The new settlement would also include non-monetary concessions. The Sacklers had previously agreed to pay $4.3 billion in Purdue’s bankruptcy case in return for sweeping legal protections that would have shielded the family from future opioid lawsuits. The states that had opposed the deal argued that the Sacklers were not paying enough to address their role in the harms caused by the opioid …